A small number of previous studies have conducted in vitro blockade of PD-1/PD-L1 in PBMC from TB patients, which have utilized either anti-PD-1 antibodies or a combination of anti-PD-L1 and anti-PD-L2 antibodies (40, 41, 73). This evidence concerns the gene PDCD1 and tuberculosis.